FDA Guidances: Agency Fine Tunes Language, May Undertake Broad Review
This article was originally published in The Tan Sheet
Executive Summary
FDA is considering undertaking a broad guidance cleanup effort, agency Chief Counsel Daniel Troy indicated May 16 during a Generic Pharmaceutical Association legal symposium in Washington, D.C
You may also be interested in...
Allen, Azar & Troy: FDA Legal Partners Streamline Enforcement Activity
HHS' decision to elevate FDA warning letter oversight from the Office of Regulatory Affairs to the Office of the Chief Counsel signals an attempt to keep a tighter rein on the agency in the absence of a commissioner
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands